(Q33377548)

26 July 2017

1 reference

title

Cognitive changes in multiple sclerosis (English)

1 reference

26 July 2017

0 references

Maria Pia Amato

1

0 references

author name string

Valentina Zipoli

series ordinal

2

1 reference

26 July 2017

Emilio Portaccio

series ordinal

3

1 reference

26 July 2017

publication date

1 October 2008

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

26 July 2017

published in

1 reference

26 July 2017

volume

8

1 reference

26 July 2017

issue

10

1 reference

26 July 2017

page(s)

1585-1596

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

26 July 2017

1 reference

Current evidence and therapeutic strategies for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Multiple sclerosis symptom management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Metamemory in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

The nature of memory impairments in multiple sclerosis: acquisition versus retrieval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Changes in neuropsychological test performance over the workday in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Neurologic impairment in multiple sclerosis and the disability status scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive impairment in probable multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Memory impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Influence of clinical variables on neuropsychological performance in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive impairment in three subtypes of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

'Subclinical MS': follow-up of four cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

The cognitive burden of multiple sclerosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive functioning in children and adolescents with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive and psychosocial features of childhood and juvenile MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Treatment of pediatric multiple sclerosis and variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Fatigue associated with multiple sclerosis: diagnosis, impact and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Depression in multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Longitudinal course of depression symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Regional hippocampal atrophy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Functional MRI in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognition in patients with multiple sclerosis After four years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Neuropsychological deficits in multiple sclerosis after acute relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

PASAT in detecting cognitive impairment in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

How to detect cognitive dysfunction at early stages of multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Reliable screening for neuropsychological impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Predicting neuropsychological abnormalities in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Minimal neuropsychological assessment of MS patients: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Neuropsychologic status in multiple sclerosis after treatment with glatiramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Donepezil for memory impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Comparison of two brief neuropsychological batteries in people with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Amantadine treatment of fatigue associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Executive functions in multiple sclerosis: an analysis of temporal ordering, semantic encoding, and planning abilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

A longitudinal study of cognition in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Benign multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1585

10.1586/14737175.8.10.1585

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference